Michael Lytton's Net Worth

$6.7 Million

Estimate Recalculated Nov 8, 2024 04:31PM EST

Who is Michael Lytton?

Michael Lytton has an estimated net worth of $6.7 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., PATHEON INC, Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc., ACADIA PHARMACEUTICALS INC, Patheon N.V., and Solexa, Inc..

SEC CIK

Michael Lytton's CIK is 0001286396

Past Insider Trading and Trends

2011 was Michael Lytton's most active year for acquiring shares with 8 total transactions. Michael Lytton's most active month to acquire stocks was the month of May. 2010 was Michael Lytton's most active year for disposing of shares, totalling 2 transactions. Michael Lytton's most active month to dispose stocks was the month of February. 2013 saw Michael Lytton paying a total of $380,183.80 for 172,540 shares, this is the most they've acquired in one year. In 2014 Michael Lytton cashed out on 619,030 shares for a total of $5,318,159.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5

EVP Corporate & Business Devel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+77.93%
8.26K
$57.31
-$128,087.85
18.87K
Mar 2
Form 4
—
0
—
—
0
Feb 23
Form 3
—
0
—
—
0
No matching records found

PATHEON INC No price found

EVP Corp Dev & Strategy and GC

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-379.03K
$9.32
-$3,532,559.60
0
Mar 11
Form 4
+26.75%
80K
$2.01
$160,800.00
379.03K
Jul 15
Form 4
+4.38%
12.54K
$3.97
$49,783.80
299.03K
Jan 14
Form 4
+38.74%
80K
$2.12
$169,600.00
286.49K
Jan 4
Form 4
+8.00%
15.29K
$3.19
$48,775.10
206.49K
Dec 21
Form 4
—
0
—
—
0
Jun 18
Form 4
+109.65%
100K
$1.15
$115,000.00
191.2K
Dec 23
Form 4
+48.78%
29.9K
$2.25
$67,244.00
91.2K
Jun 22 - Jun 23
Form 4
+74.15%
26.1K
$2.25
$58,704.00
61.3K
Jun 20 - Jun 21
Form 4
+27.08%
7.5K
$2.25
$16,875.00
35.2K
Jun 17
Form 4
∞
27.7K
$2.04
$56,508.00
27.7K
Jun 15
Form 3
—
0
—
—
0
No matching records found

Trubion Pharmaceuticals, Inc No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5,180.19%
2.16M
—
—
2.2M
Oct 23
Form 4
∞
41.61K
$13.00
$540,982.00
41.61K
Oct 17
Form 3
—
0
—
—
0
No matching records found

Cyberkinetics Neurotechnology Systems, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.58%
833.33K
$1.20
$1,000,000.80
10.54M
Oct 18
Form 4
+34.69%
2.5M
$1.20
$3,000,000.00
9.71M
Sep 26
Form 4
+4.62%
318.5K
$3.00
$955,503.00
7.21M
Nov 4
Form 3
—
0
—
—
0
No matching records found

ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 29
Form 4
+22.78%
586.4K
$6.82
$4,000,023.96
3.16M
Apr 20
Form 4
+112.31%
2.6M
$7.00
$1,995,000.00
4.91M
Jun 2
Form 3
—
0
—
—
0
No matching records found